Gapping up
In reaction to earnings/guidance:
- JEF +1.1%
Other news:
- BMRA +31.1% (entered into a General Merchandise Supplier Agreement with Walmart (WMT) for the sale of the Company's EZ Detect)
- BITF +10.8% (provides Q3 mining update; Bitcoin production up 38% over Q2)
- SPWR +9.7% (to join S&P MidCap 400)
- MRK +8% (Merck and Ridgeback's investigational oral antiviral molnupiravir reduced the risk of hospitalization or death by approximately 50 percent compared to placebo for patients with mild or moderate COVID-19 in positive interim analysis of phase 3 study)
- RIDE +5.1% (partners with Hon Hai Technology to work jointly on scalable electric vehicle programs; to purchase $50 mln of RIDE common stock)
- ZM +3.5% (Five9 and Zoom (ZM) terminate merger agreement)
- XPEV +3.1% (Sep deliveries)
- NIO +3% (Sep deliveries)
- HLBZ +2.9% (announces purchase of PIPE offering units by its CEO)
- IFF +2.4% (CEO to retire)
- COTY +2.4% (divests partial stake in Wella to KKR)
- NAT +2% (reports one of its Board members purchased 50K shares iof stock at $2.565 per share)
- GD +1.7% (awarded $480 mln Navy contract)
- QTNT +1.7% (submits MosaiQ for CE Mark)
- KDP +1.7% (reaffirms FY21 guidance; authorized a share repurchase program of up to $4 billion)
- HAE +1.6% (VASCADE MVP receives FDA indication for same-day discharge following atrial fibrillation ablation)
- OLMA +1.5% (announces trials in progress poster on OP-1250)
- LI +1.5% (Sep deliveries)
- PLBY +1.4% (Fortress Investment Group files amended 13D reflecting the sale of 428478 shares (9/2-9/27 transaction dates) )
- HLX +1.3% (enters into a new $80 mln asset-based revolving credit facility)
Analyst comments:
- GIS +1% (upgraded to Buy from Neutral at Citigroup)